ArticleThe open AIDS journal2011

A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN Trial.

K U Ulbricht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.